JC

Jie Chen

Chief Technical Operations & Quality Officer at GV20 Oncotherapy

Jie Chen has extensive work experience in the biotechnology and pharmaceutical industry. They most recently served as the Chief Technical Operations & Quality Officer at GV20 Therapeutics starting in February 2023. Prior to that, they held various roles at WuXi Biologics, including Senior Vice President of WuXi Biologics Manufacturing 11 & 18 US Operations from August 2021 to February 2023, US Manufacturing Site Head (MFG11 at Worcester, MA and MFG18 at Cranbury, NJ) from January 2019 to January 2023, and VP of CMC Operation from September 2016 to October 2020. Jie also worked at Shire as the Process Development and CMC Director from November 2015 to September 2016, at Dyax Corp as the Senior Director of Process Sciences from 2014 to 2016, as the Director of Protein Sciences from January 2008 to 2013 at Dyax Corp., and as a Scientist to Associate Director of Process Development from May 2000 to 2007 at Dyax Corp.

Jie Chen attended Rutgers University at an unspecified time, where the degree, field of study, and years of attendance are not known. Jie Chen also attended Xi'an Medical University, but again, no details regarding the degree, field of study, or duration of study are provided.

Links